Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Am J Physiol Regul Integr Comp Physiol ; 308(5): R419-30, 2015 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-25568076

RESUMEN

Sleep disorders are highly prevalent during late pregnancy and can impose adverse effects, such as preeclampsia and diabetes. However, the consequences of sleep fragmentation (SF) on offspring metabolism and epigenomic signatures are unclear. We report that physical activity during early life, but not later, reversed the increased body weight, altered glucose and lipid homeostasis, and increased visceral adipose tissue in offspring of mice subjected to gestational SF (SFo). The reversibility of this phenotype may reflect epigenetic mechanisms induced by SF during gestation. Accordingly, we found that the metabolic master switch Foxo1 was epigenetically misregulated in SFo livers in a temporally regulated fashion. Temporal Foxo1 analysis and its gluconeogenetic targets revealed that the epigenetic abnormalities of Foxo1 precede the metabolic syndrome phenotype. Importantly, regular physical activity early, but not later in life, reversed Foxo1 epigenetic misregulation and altered the metabolic phenotype in gestationally SF-exposed offspring. Thus, we have identified a restricted postnatal period during which lifestyle interventions may reverse the Foxo1 epigenetically mediated risk for metabolic dysfunction later in the life, as induced by gestational sleep disorders.


Asunto(s)
Metabolismo Energético/genética , Epigénesis Genética , Factores de Transcripción Forkhead/genética , Hígado/metabolismo , Actividad Motora , Efectos Tardíos de la Exposición Prenatal , Trastornos del Sueño-Vigilia/genética , Sueño , Adiposidad , Factores de Edad , Animales , Biomarcadores/sangre , Glucemia/metabolismo , Femenino , Proteína Forkhead Box O1 , Factores de Transcripción Forkhead/metabolismo , Regulación de la Expresión Génica , Edad Gestacional , Grasa Intraabdominal/metabolismo , Grasa Intraabdominal/fisiopatología , Estilo de Vida , Lípidos/sangre , Hígado/fisiopatología , Ratones Endogámicos C57BL , Embarazo , Factores de Riesgo , Conducta de Reducción del Riesgo , Trastornos del Sueño-Vigilia/sangre , Trastornos del Sueño-Vigilia/fisiopatología , Aumento de Peso
2.
Proc Natl Acad Sci U S A ; 106(41): 17419-24, 2009 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-19805079

RESUMEN

Knowledge of how insulin (INS) gene expression is regulated will lead to better understanding of normal and abnormal pancreatic beta cell function. We have mapped histone modifications over the INS region, coupled with an expression profile, in freshly isolated islets from multiple human donors. Unlike many other human genes, in which active modifications tend to be concentrated within 1 kb around the transcription start site, these marks are distributed over the entire coding region of INS as well. Moreover, a region of approximately 80 kb around the INS gene, which contains the {tyrosine hydroxylase (TH)-(INS)-insulin-like growth factor 2 antisense (IGF2AS)-insulin-like growth factor 2 (IGF2)} gene cluster, unusually is marked by almost uniformly elevated levels of histone acetylation and H3K4 dimethylation, extending both downstream into IGF2 and upstream beyond the TH gene. This is accompanied by islet specific coordinate expression with INS of the neighboring TH and IGF2 genes. The presence of islet specific intergenic transcripts suggests their possible function in the maintenance of this unusual large open chromatin domain.


Asunto(s)
Cromatina/genética , Insulina/genética , Islotes Pancreáticos/fisiología , Diabetes Mellitus Tipo 1/genética , Femenino , Regulación de la Expresión Génica , Humanos , Factor II del Crecimiento Similar a la Insulina/genética , Células Secretoras de Insulina/fisiología , Familia de Multigenes/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Síndrome del Ovario Poliquístico/genética , Proteínas/genética , Tirosina 3-Monooxigenasa/genética
3.
Stem Cells ; 25(12): 3223-33, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17901401

RESUMEN

Human islet-derived precursor cells (hIPCs), mesenchymal cells derived in vitro from adult pancreas, proliferate freely and do not express insulin but can be differentiated to epithelial cells that express insulin. hIPCs have been studied with the goal of obtaining large quantities of insulin-producing cells suitable for transplantation into patients suffering from type 1 diabetes. It appeared that undifferentiated hIPCs are "committed" to a pancreatic endocrine phenotype through multiple cell divisions, suggesting that epigenetic modifications at the insulin locus could be responsible. We determined patterns of histone modifications over the insulin gene in human islets and hIPCs and compared them with HeLa and human bone marrow-derived mesenchymal stem cells (hBM-MSCs), neither of which expresses insulin. The insulin gene in islets displays high levels of histone modifications (H4 hyperacetylation and dimethylation of H3 lysine 4) typical of active genes. These are not present in HeLa and hBM-MSCs, which instead have elevated levels of H3 lysine 9 dimethylation, a mark of inactive genes. hIPCs, in contrast, show significant levels of active chromatin modifications, as much as half those seen in islets, and show no measurable H3 K9 methylation. Cells expanded from a minor population of mesenchymal stromal cells found in islets exhibit the same histone modifications as established hIPCs. We conclude that hIPCs, which do not express the insulin gene, nonetheless uniquely exhibit epigenetic marks that could poise them for activation of insulin expression. This epigenetic signature may be a general mechanism whereby tissue-derived precursor cells are committed to a distinct specification. Disclosure of potential conflicts of interest is found at the end of this article.


Asunto(s)
Epigénesis Genética/genética , Regulación de la Expresión Génica/fisiología , Insulina/deficiencia , Insulina/genética , Islotes Pancreáticos/metabolismo , Células Madre Mesenquimatosas/metabolismo , Transcripción Genética/genética , Células de la Médula Ósea/citología , Células de la Médula Ósea/metabolismo , Proliferación Celular , Separación Celular , Células Cultivadas , Cromatina/genética , Cromatina/metabolismo , Marcadores Genéticos , Células HeLa , Humanos , Insulina/biosíntesis , Islotes Pancreáticos/citología , Células Madre Mesenquimatosas/citología
4.
Diabetes ; 63(10): 3230-41, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24812424

RESUMEN

Sleep fragmentation (SF) is a common condition among pregnant women, particularly during late gestation. Gestational perturbations promote the emergence of adiposity and metabolic disease risk in offspring, most likely through epigenetic modifications. Adiponectin (AdipoQ) expression inversely correlates with obesity and insulin resistance. The effects of SF during late gestation on metabolic function and AdipoQ expression in visceral white adipose tissue (VWAT) of offspring mice are unknown. Male offspring mice were assessed at 24 weeks after dams were exposed to SF or control sleep during late gestation. Increased food intake, body weight, VWAT mass, and insulin resistance, with reductions in AdipoQ expression in VWAT, emerged in SF offspring. Increased DNMT3a and -b and global DNA methylation and reduced histone acetyltransferase activity and TET1, -2, and -3 expression were detected in VWAT of SF offspring. Reductions in 5-hydroxymethylcytosine and H3K4m3 and an increase in DNA 5-methylcytosine and H3K9m2 in the promoter and enhancer regions of AdipoQ emerged in adipocytes from VWAT and correlated with AdipoQ expression. SF during late gestation induces epigenetic modifications in AdipoQ in male offspring mouse VWAT adipocytes along with a metabolic syndrome-like phenotype. Thus, altered gestational environments elicited by SF impose the emergence of adverse, long-lasting metabolic consequences in the next generation.


Asunto(s)
Adiponectina/genética , Glucemia/genética , Resistencia a la Insulina/genética , Efectos Tardíos de la Exposición Prenatal/genética , Privación de Sueño/genética , Adiponectina/metabolismo , Animales , Peso Corporal/genética , Ingestión de Alimentos/genética , Epigénesis Genética , Femenino , Masculino , Ratones , Embarazo , Efectos Tardíos de la Exposición Prenatal/metabolismo , Privación de Sueño/metabolismo
5.
Cell Metab ; 20(4): 614-25, 2014 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-25242226

RESUMEN

Adipose tissue macrophage (ATM)-driven inflammation plays a key role in insulin resistance; however, factors activating ATMs are poorly understood. Using a proteomics approach, we show that markers of classical activation are absent on ATMs from obese humans but are readily detectable on airway macrophages of patients with cystic fibrosis, a disease associated with chronic bacterial infection. Moreover, treating macrophages with glucose, insulin, and palmitate-conditions characteristic of the metabolic syndrome-produces a "metabolically activated" phenotype distinct from classical activation. Markers of metabolic activation are expressed by proinflammatory ATMs in obese humans/mice and are positively correlated with adiposity. Metabolic activation is driven by independent proinflammatory and anti-inflammatory pathways, which regulate balance between cytokine production and lipid metabolism. We identify PPARγ and p62/SQSTM1 as two key proteins that promote lipid metabolism and limit inflammation in metabolically activated macrophages. Collectively, our data provide important mechanistic insights into pathways that drive the metabolic-disease-specific phenotype of macrophages.


Asunto(s)
Tejido Adiposo/metabolismo , Macrófagos/metabolismo , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Antígenos de Superficie/metabolismo , Autofagia/efectos de los fármacos , Membrana Celular/metabolismo , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Glucosa/farmacología , Humanos , Inflamación/metabolismo , Insulina/farmacología , Metabolismo de los Lípidos/fisiología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Monocitos/citología , PPAR gamma/metabolismo , Palmitatos/farmacología , Fenotipo
6.
EMBO J ; 23(1): 138-49, 2004 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-14685282

RESUMEN

Transgenes stably integrated into cells or animals in many cases are silenced rapidly, probably under the influence of surrounding endogenous condensed chromatin. This gene silencing correlates with repressed chromatin structure marked by histone hypoacetylation, loss of methylation at H3 lysine 4, increase of histone H3 lysine 9 methylation as well as CpG DNA methylation at the promoter. However, the order and the timing of these modifications and their impact on transcription inactivation are less well understood. To determine the temporal order of these events, we examined a model system consisting of a transgenic cassette stably integrated in chicken erythroid cells. We found that histone H3 and H4 hypoacetylation and loss of methylation at H3 lysine 4 all occurred during the same window of time as transgene inactivation in both multicopy and low-copy-number lines. These results indicate that these histone modifications were the primary events in gene silencing. We show that the kinetics of silencing exclude histone H3 K9 and promoter DNA methylation as the primary causative events in our transgene system.


Asunto(s)
Silenciador del Gen/efectos de los fármacos , Histonas/metabolismo , Lisina/metabolismo , Regiones Promotoras Genéticas , Transcripción Genética , Transgenes , Acetilación , Alpharetrovirus/genética , Animales , Azacitidina/farmacología , Línea Celular , Transformación Celular Viral , Pollos , Cromatina/metabolismo , Islas de CpG , Metilación de ADN/efectos de los fármacos , Células Eritroides , Citometría de Flujo , Dosificación de Gen , Genes Reporteros , Histonas/química , Cinética , Metilación , Modelos Genéticos , Reacción en Cadena de la Polimerasa , Pruebas de Precipitina , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN
7.
Genes Dev ; 16(12): 1540-54, 2002 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-12080092

RESUMEN

Stably integrated transgenes flanked by the chicken beta-globin HS4 insulator are protected against chromosomal position effects and gradual extinction of expression during long-term propagation in culture. To investigate the mechanism of action of this insulator, we used bisulfite genomic sequencing to examine the methylation of individual CpG sites within insulated transgenes, and compared this with patterns of histone acetylation. Surprisingly, although the histones of the entire insulated transgene are highly acetylated, only a specific region in the promoter, containing binding sites for erythroid-specific transcription factors, is highly protected from DNA methylation. This critical region is methylated in noninsulated and inactive lines. MBD3 and Mi-2, subunits of the Mi-2/NuRD repressor complex, are bound in vivo to these silenced noninsulated transgenes. In contrast, insulated cell lines do not show any enrichment of Mi-2/NuRD proteins very late in culture. In addition to the high levels of histone acetylation observed across the entire insulated transgene, significant peaks of H3 acetylation are present over the HS4 insulator elements. Targeted histone acetylation by the chicken beta-globin insulator occurs independently of gene transcription and does not require the presence of a functional enhancer. We suggest that this acetylation is in turn responsible for the maintenance of a region of unmethylated DNA over the promoter. Whereas DNA methylation often leads to histone deacetylation, here acetylation appears to prevent methylation.


Asunto(s)
Adenosina Trifosfatasas , ADN Helicasas , Histonas/metabolismo , Acetilación , Animales , Autoantígenos/metabolismo , Western Blotting , Línea Celular , Separación Celular , Pollos , Islas de CpG , Metilación de ADN , ADN Complementario/metabolismo , Proteínas de Unión al ADN/metabolismo , Citometría de Flujo , Silenciador del Gen , Globinas/metabolismo , Histona Desacetilasas/metabolismo , Complejo Desacetilasa y Remodelación del Nucleosoma Mi-2 , Modelos Genéticos , Plásmidos/metabolismo , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , Unión Proteica , Estructura Terciaria de Proteína , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Factores de Tiempo , Factores de Transcripción/metabolismo , Transcripción Genética , Transgenes
8.
Proc Natl Acad Sci U S A ; 99 Suppl 4: 16433-7, 2002 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-12154228

RESUMEN

Insulators are DNA sequence elements that can serve in some cases as barriers to protect a gene against the encroachment of adjacent inactive condensed chromatin. Some insulators also can act as blocking elements to protect against the activating influence of distal enhancers associated with other genes. Although most of the insulators identified so far derive from Drosophila, they also are found in vertebrates. An insulator at the 5' end of the chicken beta-globin locus marks a boundary between an open chromatin domain and a region of constitutively condensed chromatin. Detailed analysis of this element shows that it possesses both enhancer blocking activity and the ability to screen reporter genes against position effects. Enhancer blocking is associated with binding of the protein CTCF; sites that bind CTCF are found at other critical points in the genome. Protection against position effects involves other properties that appear to be associated with control of histone acetylation and methylation. Insulators thus are complex elements that can help to preserve the independent function of genes embedded in a genome in which they are surrounded by regulatory signals they must ignore.


Asunto(s)
Cromatina/genética , Elementos de Facilitación Genéticos , Silenciador del Gen , Animales , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA